Arnhold LLC Curis Inc Transaction History

Arnhold LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.57 - $0.99 $28,499 - $49,500	-50,000 Reduced 12.41%	353,003 $292,000
Q4 2020 Feb 08, 2021	SELL	$1.08 - $8.2 $28,103 - $213,380	-26,022 Reduced 6.07%	403,003 $3.3 Million
Q3 2020 Nov 13, 2020	BUY	$0.95 - $1.42 $12,360 - $18,475	13,011 Added 3.13%	429,025 $502,000
Q2 2020 Aug 03, 2020	SELL	$0.63 - $1.7 $190,419 - $513,830	-302,253 Reduced 42.08%	416,014 $503,000
Q1 2020 Apr 17, 2020	BUY	$0.67 - $1.85 $202,509 - $559,168	302,253 Added 72.65%	718,267 $506,000
Q3 2019 Oct 29, 2019	SELL	$1.74 - $2.83 $16,223 - $26,386	-9,324 Reduced 2.19%	416,014 $932,000
Q1 2019 May 09, 2019	SELL	$0.78 - $2.01 $54,320 - $139,980	-69,642 Reduced 14.07%	425,338 $846,000
Q4 2018 Feb 08, 2019	SELL	$0.62 - $2.25 $55,037 - $199,732	-88,770 Reduced 15.21%	494,980 $341,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $1.01 Million - $1.96 Million	583,750 New	583,750 $1.01 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

Stay updated on Arnhold LLC with notifications on news.